Read the source that answers your question

For a claim about results, read the trial

Ask which study supports the result in an offer. Ask who took part, what the comparison was and whether it studied the product being discussed.

• The main semaglutide weight trial: STEP 1

  In STEP 1, adults without diabetes lost, on average, 14.9% of their weight on semaglutide and 2.4% on a dummy injection over 68 weeks.

Both groups also had support with food and activity. The drug maker funded the trial.

The result is an average for a studied group. It does not promise the same change for each person.

• The follow-up after treatment stopped

  A later report on some of the trial participants. It describes weight returning after treatment ended, rather than testing a plan for every patient.

For a claim about approval, read the official medicine information

FDA reviews medicines for specific uses; Food and Drug Administration is the agency’s full name. The official medicine information, called the label, lists those uses and warnings.

• Wegovy (semaglutide) prescribing information

  Useful for the weight-management product and its label concerns. Trial results do not erase the label’s limits.

• Ozempic (semaglutide) injection prescribing information

  Useful for the diabetes injection. Do not transfer its approved uses to a different product or form.

• FDA’s compounding and shortage updates

  A dated record. As of September 26, 2026, semaglutide injections were not on the national shortage list.

For a doctor or pharmacy, check the state licence information

• Find the state agency that licenses your doctor

  Use this list to find the state agency’s website. Check the doctor’s licence and any reported penalties or formal charges. The list includes agencies for doctors with either an MD or a DO degree; some states license these doctors through separate agencies. It does not rank their care.

• State pharmacy licence searches via FDA

  Start with the pharmacy name. A licence record does not prove that each product is made or dispensed properly.

For a Medicare question, read the program rules

• Medicare’s weight-drug coverage explanation

  As of September 26, 2026, the temporary Bridge and ordinary prescription coverage followed separate payment routes.

• Detailed Medicare Bridge criteria

  The proposed use, health history and plan type affect which route applies. Coverage eligibility is not a promise of payment.

Keep the source beside the claim you are checking. If the answer stays unclear, bring both to the conversation.